TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,064,000 | -49.2% | 337,609 | -8.0% | 0.05% | -41.0% |
| Q4 2021 | $17,839,000 | -32.4% | 366,837 | -7.7% | 0.08% | -34.5% |
| Q3 2021 | $26,406,000 | -21.3% | 397,502 | -7.6% | 0.12% | -17.4% |
| Q2 2021 | $33,572,000 | -13.0% | 430,300 | +1.0% | 0.14% | -15.8% |
| Q1 2021 | $38,579,000 | -17.2% | 425,873 | +11.4% | 0.17% | -35.0% |
| Q4 2020 | $46,596,000 | +19.6% | 382,411 | -13.1% | 0.26% | +30.8% |
| Q3 2020 | $38,946,000 | +37.5% | 439,823 | -0.7% | 0.20% | +24.8% |
| Q2 2020 | $28,315,000 | +459.1% | 442,714 | +290.4% | 0.16% | +403.1% |
| Q1 2020 | $5,064,000 | – | 113,407 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |